Bio-Rad Financial Statements From 2010 to 2024

Bio-Rad Laboratories Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 12.9 B 12.3 B 7.2 B Slightly volatile Short and Long Term Debt Total 1.5 B 1.4 B 576.9 M Slightly volatile Other Current Liabilities 316.6 M 301.6 M 244.8 M Slightly volatile Total Current Liabilities 338.4 M 522.8 M 492.7 M Slightly volatile Total Stockholder Equity 9.2 B 8.7 B 5.1 B Slightly volatile Property Plant And Equipment Net 759.9 M 723.7 M 521.4 M Slightly volatile Retained Earnings 9.7 B 9.3 B 4.8 B Slightly volatile Cash 257.1 M 404 M 427.1 M Pretty Stable Non Current Assets Total 9.7 B 9.3 B 5.2 B Slightly volatile Cash And Short Term Investments 1.7 B 1.6 B 959.1 M Slightly volatile Net Receivables 272.4 M 489 M 382.3 M Slightly volatile Common Stock Shares Outstanding 29.1 M 29.2 M 28.9 M Slightly volatile Liabilities And Stockholders Equity 12.9 B 12.3 B 7.2 B Slightly volatile Non Current Liabilities Total 3.2 B 3 B 1.6 B Slightly volatile Inventory 819.5 M 780.5 M 542.5 M Slightly volatile Other Current Assets 92.3 M 171.7 M 134.2 M Very volatile Total Liabilities 3.7 B 3.6 B 2.1 B Slightly volatile Total Current Assets 3.2 B 3 B 2 B Slightly volatile Short Term Debt 33.9 M 40.9 M 41.8 M Pretty Stable Accounts Payable 116.6 M 144.6 M 177.8 M Pretty Stable Intangible Assets 188.7 M 320.5 M 212.2 M Slightly volatile Common Stock 2.6 K 2.7 K 836.1 K Slightly volatile Current Deferred Revenue 37.5 B 35.8 B 4.9 B Slightly volatile Common Stock Total Equity 3.3 K 3.5 K 136.2 K Pretty Stable Property Plant And Equipment Gross 1.7 B 1.8 B 92.9 B Pretty Stable Short Term Investments 1.3 B 1.2 B 532 M Slightly volatile Good Will 419.6 M 413.6 M 396.3 M Very volatile Net Tangible Assets 5.4 B 10.6 B 5 B Slightly volatile Noncontrolling Interest In Consolidated Entity 428 K 481.5 K 524.3 K Slightly volatile Long Term Debt 1.3 B 1.2 B 565.2 M Pretty Stable Retained Earnings Total Equity 12 B 11.4 B 5.2 B Slightly volatile Long Term Debt Total 1.1 B 1.1 B 550.4 M Pretty Stable Capital Surpluse 384.1 M 514.6 M 344.3 M Slightly volatile Deferred Long Term Liabilities 2.1 B 2 B 931.6 M Slightly volatile Non Current Liabilities Other 216 M 195.1 M 185.9 M Slightly volatile Deferred Long Term Asset Charges 12.4 M 13.9 M 15.2 M Slightly volatile Property Plant Equipment 538.6 M 573.4 M 488.8 M Slightly volatile Long Term Investments 5.1 B 7.7 B 3.8 B Slightly volatile Other Liabilities 1.3 B 2.3 B 1 B Slightly volatile Short and Long Term Debt 461.7 K 486 K 203 M Slightly volatile Net Invested Capital 7 B 9.9 B 5 B Slightly volatile Net Working Capital 1.9 B 2.5 B 1.6 B Slightly volatile Capital Stock 2.4 K 2.7 K 2.9 K Slightly volatile Capital Lease Obligations 165 M 205.9 M 206.6 M Slightly volatile
Bio-Rad Laboratories Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 202 M 192.4 M 107.1 M Slightly volatile Interest Expense 51.9 M 49.4 M 30.9 M Very volatile Selling General Administrative 475.9 M 846.8 M 727.3 M Slightly volatile Total Revenue 1.4 B 2.7 B 2.1 B Slightly volatile Gross Profit 769.3 M 1.4 B 1.2 B Slightly volatile Other Operating Expenses 1.2 B 2.3 B 1.9 B Slightly volatile Cost Of Revenue 1.3 B 1.2 B 992.5 M Slightly volatile Total Operating Expenses 613.7 M 1 B 925.7 M Slightly volatile Research Development 161.8 M 226.9 M 203.8 M Slightly volatile Non Operating Income Net Other 54.1 M 51.5 M 21.8 M Slightly volatile Minority Interest 36 K 18.9 K 31.5 K Slightly volatile Non Recurring 353.2 M 336.4 M 173.3 M Slightly volatile Interest Income 101.2 M 96.4 M 31.5 M Slightly volatile Reconciled Depreciation 111.4 M 144.2 M 141.8 M Slightly volatile Selling And Marketing Expenses 1.2 M 1.3 M 1.5 M Slightly volatile
Bio-Rad Laboratories Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 271.2 M 434.5 M 462.2 M Very volatile Depreciation 202 M 192.4 M 137 M Slightly volatile Capital Expenditures 84.5 M 156.7 M 113 M Pretty Stable Total Cash From Operating Activities 393.7 M 374.9 M 296.1 M Slightly volatile End Period Cash Flow 286.4 M 404.4 M 429.6 M Pretty Stable Change Receivables 82.3 M 78.4 M 30.8 M Slightly volatile Dividends Paid 105.1 B 100.1 B 21.1 B Slightly volatile Cash Flows Other Operating 137.9 M 145.2 M 264.1 M Very volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 3.71 3.5307 3.2598 Slightly volatile PTB Ratio 2.15 1.079 1.8203 Slightly volatile Days Sales Outstanding 87.31 66.8191 68.6533 Pretty Stable Book Value Per Share 314 299 174 Slightly volatile Operating Cash Flow Per Share 13.48 12.8366 10.0993 Slightly volatile Stock Based Compensation To Revenue 0.0241 0.0229 0.0125 Slightly volatile Capex To Depreciation 1.4 0.96 0.9684 Pretty Stable PB Ratio 2.15 1.079 1.8203 Slightly volatile EV To Sales 4.1 3.9056 3.3257 Slightly volatile Inventory Turnover 2.19 1.5886 1.9156 Pretty Stable Days Of Inventory On Hand 149 230 191 Pretty Stable Payables Turnover 5.69 8.5733 7.6168 Slightly volatile Sales General And Administrative To Revenue 0.43 0.42 0.3787 Pretty Stable Research And Ddevelopement To Revenue 0.1 0.085 0.0949 Pretty Stable Capex To Revenue 0.0697 0.0587 0.0549 Pretty Stable Cash Per Share 57.98 55.2177 32.7398 Slightly volatile POCF Ratio 15.18 25.1539 26.5811 Slightly volatile Capex To Operating Cash Flow 0.4 0.4179 0.5511 Slightly volatile Days Payables Outstanding 58.92 42.574 48.8113 Slightly volatile EV To Operating Cash Flow 17.4 27.825 27.5784 Slightly volatile Intangibles To Total Assets 0.0567 0.0597 0.1242 Slightly volatile Current Ratio 6.12 5.8308 4.0248 Slightly volatile Tangible Book Value Per Share 288 274 153 Slightly volatile Receivables Turnover 3.78 5.4625 5.3723 Pretty Stable Graham Number 402 383 345 Slightly volatile Shareholders Equity Per Share 314 299 174 Slightly volatile Debt To Equity 0.13 0.1361 0.2055 Slightly volatile Capex Per Share 5.63 5.3641 4.0572 Slightly volatile Revenue Per Share 96.03 91.4534 75.581 Slightly volatile Interest Debt Per Share 44.55 42.4313 19.8133 Slightly volatile Debt To Assets 0.0919 0.0968 0.12 Slightly volatile Short Term Coverage Ratios 810 771 500 Slightly volatile Operating Cycle 292 297 264 Slightly volatile Price Book Value Ratio 2.15 1.079 1.8203 Slightly volatile Days Of Payables Outstanding 58.92 42.574 48.8113 Slightly volatile Price To Operating Cash Flows Ratio 15.18 25.1539 26.5811 Slightly volatile Company Equity Multiplier 2.19 1.407 1.5858 Slightly volatile Long Term Debt To Capitalization 0.11 0.1198 0.1406 Slightly volatile Total Debt To Capitalization 0.11 0.1198 0.1521 Slightly volatile Debt Equity Ratio 0.13 0.1361 0.2055 Slightly volatile Quick Ratio 4.55 4.3378 2.9339 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.74 2.393 2.4405 Slightly volatile Net Income Per E B T 0.58 0.7497 0.7564 Very volatile Cash Ratio 0.41 0.7727 0.8171 Pretty Stable Cash Conversion Cycle 239 254 220 Pretty Stable Operating Cash Flow Sales Ratio 0.08 0.1404 0.1212 Slightly volatile Days Of Inventory Outstanding 149 230 191 Pretty Stable Days Of Sales Outstanding 87.31 66.8191 68.6533 Pretty Stable Cash Flow Coverage Ratios 0.3 0.3151 19.1023 Pretty Stable Price To Book Ratio 2.15 1.079 1.8203 Slightly volatile Fixed Asset Turnover 5.53 3.6909 4.7057 Slightly volatile Capital Expenditure Coverage Ratio 1.74 2.393 2.4405 Slightly volatile Price Cash Flow Ratio 15.18 25.1539 26.5811 Slightly volatile Debt Ratio 0.0919 0.0968 0.12 Slightly volatile Cash Flow To Debt Ratio 0.3 0.3151 19.1023 Pretty Stable Price Sales Ratio 3.71 3.5307 3.2598 Slightly volatile Asset Turnover 0.21 0.2172 0.4842 Slightly volatile Gross Profit Margin 0.63 0.5358 0.5575 Pretty Stable Price Fair Value 2.15 1.079 1.8203 Slightly volatile
Bio-Rad Laboratories Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 919.2 M 875.4 M 906.2 M Slightly volatile Enterprise Value 1 B 952.4 M 987.1 M Slightly volatile

Bio-Rad Fundamental Market Drivers

About Bio-Rad Laboratories Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio-Rad Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:

How To Invest In Bio-Rad Details

Is Bio-Rad Stock a good investment? Details

What is Bio-Rad Laboratories' Net Worth? Details

Largest Life Sciences Tools & Services Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Financial Analysis Details

Buy or Sell Advice Details

Technical Analysis Details

Please note, there is a significant difference between Bio-Rad Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio-Rad Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio-Rad Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.